Abstract:Objective: We aimed to explore the feasibility of a novel apoptosis imaging agent (99)mTc-DCD, and to study the uptake of apoptotic cells in vitro and the distribution characteristics in normal Kunming mice. Methods: CBT-DEVD was dissolved in 2% DMSO, and DTPAA was added to make DTPA-CBT-DEVD (DCD) at room temperature for 30 minutes. Isolation and purification were performed by High Performance Liquid Chromatography (HPLC) purification. Moreover, mass spectrometer and ultraviolet spectrum were used to verify the chemical molecular structure. (99)mTc-DCD was made in combination with SnCl2 by direct labeling method and was used to detect the radiochemical purity and stability in vitro. The fresh prepared caspase-3 work buffe, 5U caspase-3 enzyme solution and 10 mu Ci(99)mTc-DCD solution were successively added, and mixed fully in the test tube. After 2 hours the reaction, the nanoparticles formed by copper mesh were observed by fluoroscopy. In addition, no caspase-3 was added in the control group. Subsequently. the supernatant was discarded and the radioactive count was measured. Besides, (99)mTc-DCD was added to the normal and cisplatin induced apoptotic Hela cell culture medium to observe the cell uptake in vitro. Each healthy Kunming mouse was injected with 0.2mCi(99)mTc-DCD from the tail vein, to perform SPECT imaging and study their biological distribution. Results: DCD was made after mixing with CBT-DEVD and DTPAA for 30 minutes, and its molecular weight was 1,370 g/mol by mass spectrometry. According to direct labeling method, the labeling rate of (99)mTc-DCD was 96%. After left 30 minutes and 120 minutes in fresh human serum, radiochemical purity was 91.5% and 90.8%, respectively. Besides, radiochemical purity was 90.0% after left 5 hours in normal saline and serum. (99)mTc-DCD reacted with caspase-3 enzyme for 2 hours in vitro, and transmission electron microscope showed that nanoparticles with an average diameter of about 500 nm formed. The radioactivity count of precipitation in the test tube was significantly about 3.1 times higher than that of the control tube. The cell uptake rate of (99)mTc-DCD in the apoptotic model of Hela cells was significantly higher than that in normal Hela cells (P < 0.01). In addition, cisplatin induced apoptosis of Hela cells was positive in term of caspase-3 expression. The biological distribution of (99)mTc-DCD in normal Kunming mice showed that the blood clearance rate of (99)mTc-DCD was faster and mainly excreted by the kidneys. Conclusion: (99)mTc-DCD, an apoptotic probe made by direct labeling method, could be self-assembled into nanoparticles after caspase-3 recognition and shearing, thus enriching the apoptotic cells and playing the role of signal amplification. In addition, (99)mTc-DCD labeled method was simple and convenient with high labeling rate, good stability and ideal cell uptake in vitro. The imaging in mice showed that it was mainly excreted through the kidneys. Therefore, (99)mTc-DCD was a potential imaging agent for apoptosis, which was expected to be used to evaluate the efficacy of radiotherapy and chemotherapy, and to detect the apoptotic state of ischemic tissues. Besides, further studies were performed to confirm its effect of clinical application.

Targeted Imaging of Activated Caspase-3 in the Central Nervous System by a Dual Functional Nano-Device.

Two-Photon Enzymatic Probes Visualizing Sub-cellular/Deep-brain Caspase Activities in Neurodegenerative Models

Real-time Monitoring of Cell Apoptosis and Drug Screening Using Fluorescent Light-Up Probe with Aggregation-Induced Emission Characteristics.

Caspase-responsive Smart Gadolinium-Based Contrast Agent for Magnetic Resonance Imaging of Drug-Induced Apoptosis.

An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging

Targeting Caspase-3 As Dual Therapeutic Benefits by Rnai Facilitating Brain-Targeted Nanoparticles in A Rat Model of Parkinson'S Disease

A Caspase-3-activatable Bimodal Probe for Photoacoustic and Magnetic Resonance Imaging of Tumor Apoptosis in Vivo.

Poly Β-Cyclodextrin/tpdye Nanomicelle-Based Two-Photon Nanoprobe for Caspase-3 Activation Imaging in Live Cells and Tissues.

Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-triggered nanoaggregation probe.

Caspase-3-Triggered Intracellular Gadolinium Nanoparticle Formation for T 1 -Weighted Magnetic Resonance Imaging of Apoptosis In Vivo

In Situ Activation And Monitoring Of The Evolution Of The Intracellular Caspase Family

Light-up Bioprobe with Aggregation-Induced Emission Characteristics for Real-Time Apoptosis Imaging in Target Cancer Cells.

Controlled Intracellular Self-Assembly and Disassembly of 19F Nanoparticles for MR Imaging of Caspase 3/7 in Zebrafish.

A Photoacoustic Probe for the Imaging of Tumor Apoptosis by Caspase‐Mediated Macrocyclization and Self‐Assembly

Radiopharmacological evaluation of a caspase-3 responsive probe with optimized pharmacokinetics for PET imaging of tumor apoptosis

Dual-Responsive DNA Nanodevice for the Available Imaging of an Apoptotic Signaling Pathway in Situ

Molecular imaging of cell death in vivo by a novel small molecule probe

Cell-permeable [99mTc(CO3)]-labeled fluorogenic caspase 3 substrate for dual-modality detection of apoptosis.

Synthesis And Imaging Of An Apoptotic Probe (99)Mtc-Dtpa-Cbt-Devd With Caspase-3 Controlled Self-Assembly Of Nanoparticles

Promoted “Click” SERS Detection for Precise Intracellular Imaging of Caspase-3